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In the original publication, author correction was missed 
to incorporate under the section heading “Western blot and 
flow cytometry”. The complete text is given here.
Western blot and flow cytometry
Cells were stimulated as before with IL-39 (100 ng/ml) or 
IL-6 (20 ng/ml) (Peprotech). Cells were lysed with CelLytic 
M lysis buffer (Sigma-Aldrich), containing protease inhibi-
tor cocktail (Roche Applied Bioscience, Rotkreuz, Swit-
zerland) and phosphatase inhibitor (Thermofisher). Protein 
concentration was determined by Bradford Assay, and 30 μg 
of total protein was separated on any kDa mini protean gel 
(Bio-Rad). Proteins were blotted onto 0.2 μm PVDF trans-
blot pack (Bio-Rad). Membranes were incubated with either 
mouse anti-human GAPDH (Santa Cruz 1:10,000), mouse 
anti-human STAT3, or mouse anti-human phospho-STAT3 
(both Cell Signaling, 1:1000), in 5% BSA/TBST overnight 
at 4 °C. Membranes were subsequently incubated with sec-
ondary antibody, HRP conjugated donkey anti-mouse (Santa 
Cruz, 1:5000) for 1 h at room temperature. Substrate solu-
tion A and B was from GE healthcare. For flow cytometry 
analysis, cells were stimulated as before. Using IntraPrep 
Permeabilization kit (Beckman Coulter) according to the 
manufacturer’s instructions, cells were stained with mouse 
anti-human phospho-STAT3 or isotype control (PE-Cya-
nine7, eBioscience, both 1:50). Cells were analysed using 
the LSRII (BD Biosciences) and a FlowJo software (Tree 
Star Software, San Carlos, California, USA).
The original article has been corrected.
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